why choose us

First received: August 30, 2023

Clinical Trial: A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chemotherapy-induced Diarrhea

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Sequential Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of SK10 Powders (Inactivated Bacteroides Fragilis) in Healthy Adult Su

Brief Summary: The purpose of this study is to assess the safety and tolerability of orally administered SK10 powders in healthy adult subjects at three dose levels, following single and multiple doses.

Read more